MENU

Clinical Trials

A clinical trial is a research study that allows volunteers to receive treatment with a drug or device currently under research testing by a pharmaceutical or biotechnology company. These companies carefully select qualified physicians who serve as "investigators” to lead the study trials.

Arkansas Children's offers opportunities to the community to participate in many studies. Use the search fields below to review the current available studies.

If you have questions about volunteering for research studies, please visit our Frequently Asked Questions page. 

If would like to be contacted about clinical research opportunities, consider joining our Research Registry or sign up to receive text updates on your mobile device.  CLICK HERE to learn more. 

See our currently enrolling studies list.

Title:  
DMID 16-0095 CMV
Description:  

Newborns greater than or equal to 32 weeks gestation will be screened for congenital Cytomegalovirus (CMV) infection. Congenital infections occur while a baby is still in the mother’s womb. It is estimated that 5 to 10 out of every 1000 babies born will have a congenital CMV infection. Although most babies with congenital CMV infection do not have any problems due to the virus, around 15% will have hearing loss, visual problems, and/or physical or developmental disabilities. The hearing loss due to congenital CMV infection can be present at birth or can develop later during childhood. Overall, congenital CMV is a rare infection at birth, but it accounts for 21% of hearing loss at birth and 24% of hearing loss by age 4. 

Newborns that are screened and confirmed to have congenital CMV infection will be offered enrollment into either the observational phase or the treatment phase of the study. This study is being done to evaluate if treatment with an approved drug called Valganciclovir will reduce the risk of hearing loss in babies with congenital CMV were born with no outward symptoms of the infection.

Study Eligibility:  
newborns greater than or equal to 32 weeks gestation
Content Study Link:  
Principal Investigator:  
Category:  
Infection or Infectious Disease
Contact Information:  
Robin Gibson 501-364-1542 or Natalie James 501-364-2251
Inclusion/Notes: